KL-6, a human MUC1 mucin, is expressed early in premature lung

A P Sun1, Y Ohtsuki, J Fujita

  • 1Department of Pathology, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.

Respiratory Medicine
|August 20, 2003
PubMed

Insights

This study reveals that KL-6, a marker for MUC1 antigens, is present in developing lungs, suggesting its role in lung morphogenesis and function in premature infants.

Area of Science:

  • Pulmonology
  • Developmental Biology
  • Biochemistry

Background:

  • KL-6 is a MUC1 antigen expressed on type II pneumocytes, with serum levels correlating to interstitial pneumonia activity.
  • MUC1 expression is linked to epithelial and glandular formation during embryonic development.

Purpose of the Study:

  • To investigate the role of KL-6 in lung morphogenesis in premature infants.
  • To examine KL-6 expression in developing lung tissue.

Main Methods:

  • Immunohistochemistry was used to analyze KL-6 expression in 35 neonatal and infant lung tissue specimens (23-40 weeks gestational age).
  • Antibody against surfactant protein A (SP-A) was used as a marker for type II pneumocytes.
  • Hyaline membranes (HMs) were assessed in the specimens.

Main Results:

  • KL-6 staining was strongly positive in alveolar epithelial cells and HMs in infants with gestational age >23 weeks.
  • KL-6 was detected in hyaline membranes in 13 out of 35 cases.
  • PE10 immunoreaction varied with gestational age and postnatal survival.

Conclusions:

  • KL-6 is expressed early in premature lungs.
  • KL-6 may play a significant role in the morphogenesis and function of the developing lung during early gestation.

Related Concept Videos